• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.48% Nasdaq Down0.40%

    Alger Health Sciences A (AHSAX)

    23.30 Up 0.07(0.30%) May 6

    Profile as of Apr 29, 2015Get Profile for:
    Alger Health Sciences A
    Alger Funds111 Fifth AvenueNew York, NY 10003
    Map
    Phone: 800-992-3863
    Fund Overview 
    Category:Health
    Fund Family:Alger
    Net Assets:206.03M
    Year-to-Date Return:5.11%
    Yield:0.56%
    Morningstar Rating:2 stars
    Fund Inception Date:May 1, 2002
    Morningstar Style Box 
    Health
    [View Category Definition]
    View Top Health Funds
    About the Morningstar Style Box
    Management Information 
    Teresa C. McRoberts
    Lead Manager since Feb 12, 2015
    Teresa is the Founder and Portfolio Manager of Bienville Health Science Partners, LP, a Bienville Capital Management fund. She has over 30 years of experience in healthcare as an investment banker, analyst and portfolio manager and is solely focused on the management of Bienville Health Science Partners, LP. Prior to partnering with Bienville in September 2013, Teresa spent much of the previous 15 years managing various long-only and long-short funds as a lead portfolio manager at Fred Alger, Morgan Stanley and Citibank. She has worked with Ralph Reynolds previously serving as the healthcare portfolio manager at Carlyle Blue Wave. Prior to her role as a portfolio manager, she spent two years as a pharmaceutical analyst and seven years in healthcare-focused corporate finance and mergers and acquisitions. After college, Teresa worked at Cambridge Associates for three years in Boston, MA.
    Investment Information 
    Min Initial Investment:1,000
    Min Initial Investment, IRA:500
    Min Initial Investment, AIP:500
    Min Subsequent Investment:50
    Min Subsequent Investment, IRA:50
    Min Subsequent Investment, AIP:50
    AHSAX can be purchased from 122 brokerages.

    Fund Summary 
    The investment seeks long-term capital appreciation. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can also invest in derivative instruments.

    Fund Operations 
    Last Dividend (Dec 17, 2014) : 0.00
    Last Cap Gain : 0.00
    Annual Holdings Turnover (May 4, 2015) : 167.94%
    Average for Category:51.10%
    Fees & Expenses 
    ExpenseAHSAXCategory Avg
    Annual Report Expense Ratio (net):1.31%1.43%
    Prospectus Net Expense Ratio:1.31%N/A
    Prospectus Gross Expense Ratio:1.31%N/A
    Max 12b1 Fee:0.25%N/A
    Max Front End Sales Load:5.25%5.28%
    Max Deferred Sales Load: N/A2.37%
    3 Yr Expense Projection*:918603
    5 Yr Expense Projection*:1,205924
    10 Yr Expense Projection*:2,0211,815
    * Per $10,000 invested